Patrick B Ryan

发表

Discussion: An estimate of the science-wise false discovery rate and application to the top medical literature.

David Madigan, Martijn J Schuemie, Marc A Suchard, 2014, Biostatistics.

PheValuator: Development and evaluation of a phenotype algorithm evaluator

George Hripcsak, Patrick B Ryan, Joel N Swerdel, 2019, J. Biomed. Informatics.

Response to comment on 'empirical assessment of methods for risk identification in healthcare data'.

David Madigan, Patrick B Ryan, Paul E Stang, 2013, Statistics in medicine.

Improving reproducibility by using high-throughput observational studies with empirical calibration

George Hripcsak, David Madigan, Martijn J Schuemie, 2018, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

Supplementing claims data analysis using self-reported data to develop a probabilistic phenotype model for current smoking status

Patrick B Ryan, Jenna M Reps, Peter R Rijnbeek, 2019, J. Biomed. Informatics.

Multiple Self‐Controlled Case Series for Large‐Scale Longitudinal Observational Databases

David Madigan, Martijn J Schuemie, Marc A Suchard, 2013, Biometrics.

A plea to stop using the case‐control design in retrospective database studies

George Hripcsak, Martijn J Schuemie, Marc A Suchard, 2019, Statistics in medicine.

A curated and standardized adverse drug event resource to accelerate drug safety research

Juan M Banda, Nigam H Shah, Nicholas P Tatonetti, 2016, Scientific Data.

Erratum to: Large-Scale Evidence Generation and Evaluation across a Network of Databases (LEGEND): Assessing Validity Using Hypertension as a Case Study

George Hripcsak, David Madigan, Martijn J Schuemie, 2021, J. Am. Medical Informatics Assoc..

Empirical Performance of the Calibrated Self-Controlled Cohort Analysis Within Temporal Pattern Discovery: Lessons for Developing a Risk Identification and Analysis System

David Madigan, Martijn J Schuemie, Patrick B Ryan, 2013, Drug Safety.

Incidence of diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors and other antihyperglycemic agents.

Martijn J Schuemie, Zhong Yuan, Jesse A Berlin, 2017, Diabetes research and clinical practice.

Design considerations in an active medical product safety monitoring system

Malcolm Maclure, Sengwee Toh, Jeremy A Rassen, 2012, Pharmacoepidemiology and drug safety.

Empirical Performance of LGPS and LEOPARD: Lessons for Developing a Risk Identification and Analysis System

David Madigan, Martijn J Schuemie, Patrick B Ryan, 2013, Drug Safety.

Patterns in nursing home medication errors: disproportionality analysis as a novel method to identify quality improvement opportunities

Patrick B Ryan, Richard A Hansen, P. Ryan, 2010, Pharmacoepidemiology and drug safety.

Empirical Performance of a New User Cohort Method: Lessons for Developing a Risk Identification and Analysis System

David Madigan, Martijn J Schuemie, Ivan Zorych, 2013, Drug Safety.

Empirical Performance of the Self-Controlled Case Series Design: Lessons for Developing a Risk Identification and Analysis System

David Madigan, Martijn J Schuemie, Marc A Suchard, 2013, Drug Safety.

Atypical Antipsychotics and the Risk of Falls and Fractures Among Older Adults: An Emulation Analysis and an Evaluation of Additional Confounding Control Strategies

Martijn J Schuemie, Patrick B Ryan, M. Schuemie, 2017, Journal of clinical psychopharmacology.

Design and validation of a data simulation model for longitudinal healthcare data.

Patrick B Ryan, Stephanie J. Reisinger, Stephanie J Reisinger, 2011, AMIA ... Annual Symposium proceedings. AMIA Symposium.

Evaluating Performance of Risk Identification Methods Through a Large-Scale Simulation of Observational Data

Martijn J Schuemie, Patrick B Ryan, M. Schuemie, 2013, Drug Safety.

Empirical Performance of the Case–Control Method: Lessons for Developing a Risk Identification and Analysis System

David Madigan, Martijn J Schuemie, Patrick B Ryan, 2013, Drug Safety.

Detecting adverse drug reactions following long-term exposure in longitudinal observational data: The exposure-adjusted self-controlled case series

David Madigan, Martijn J Schuemie, Patrick B Ryan, 2016, Statistical methods in medical research.

Interpreting observational studies: why empirical calibration is needed to correct p-values

William DuMouchel, David Madigan, Martijn J Schuemie, 2013, Statistics in medicine.

Evaluation of Disproportionality Safety Signaling Applied to Healthcare Databases

William DuMouchel, David Madigan, Martijn J Schuemie, 2013, Drug Safety.

Identifying the DEAD: Development and Validation of a Patient-Level Model to Predict Death Status in Population-Level Claims Data

Patrick B Ryan, Peter R Rijnbeek, P. Ryan, 2019, Drug safety.

Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis

George Hripcsak, David Madigan, Martijn J Schuemie, 2019, The Lancet.

The impact of standardizing the definition of visits on the consistency of multi-database observational health research

Patrick B Ryan, P. Ryan, E. Voss, 2015, BMC Medical Research Methodology.